Cytokine MIF Enhances Blood-Brain Barrier Permeability: Impact for Therapy in Ischemic Stroke

Yu Chuan Liu, Yung Hsu Tsai, Sung Chun Tang, Houng Chi Liou, Kai Hsiang Kang, Horng Huei Liou, Jiann Shing Jeng, Wen Mei Fu

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Ischemic stroke is a devastating disease with limited therapeutic options. It is very urgent to find a new target for drug development. Here we found that the blood level of MIF in ischemic stroke patients is upregulated. To figure out the pathological role of MIF in ischemic stroke, both in vitro and in vivo studies were conducted. For in vitro studies, primary cortical neuron cultures and adult rat brain endothelial cells (ARBECs) were subjected to oxygen-glucose deprivation (OGD)/reoxygenation. Middle cerebral artery occlusion (MCAo) rodent models were used for in vivo studies. The results show that MIF exerts no direct neuronal toxicity in primary culture but disrupts tight junction in ARBECs. Furthermore, administration of MIF following MCAo shows the deleterious influence on stroke-induced injury by destroying the tight junction of blood-brain barrier and increasing the infarct size. In contrast, administration of MIF antagonist ISO-1 has the profound neuroprotective effect. Our results demonstrate that MIF might be a good drug target for the therapy of stroke.

Original languageEnglish
Article number743
JournalScientific Reports
Volume8
Issue number1
DOIs
Publication statusPublished - Dec 1 2018
Externally publishedYes

Fingerprint

Blood-Brain Barrier
Permeability
Stroke
Cytokines
Tight Junctions
Middle Cerebral Artery Infarction
Endothelial Cells
Therapeutics
Brain
Neuroprotective Agents
Rodentia
Oxygen
Neurons
Glucose
Drug Therapy
Wounds and Injuries
Pharmaceutical Preparations
In Vitro Techniques

ASJC Scopus subject areas

  • General

Cite this

Cytokine MIF Enhances Blood-Brain Barrier Permeability : Impact for Therapy in Ischemic Stroke. / Liu, Yu Chuan; Tsai, Yung Hsu; Tang, Sung Chun; Liou, Houng Chi; Kang, Kai Hsiang; Liou, Horng Huei; Jeng, Jiann Shing; Fu, Wen Mei.

In: Scientific Reports, Vol. 8, No. 1, 743, 01.12.2018.

Research output: Contribution to journalArticle

Liu, Yu Chuan ; Tsai, Yung Hsu ; Tang, Sung Chun ; Liou, Houng Chi ; Kang, Kai Hsiang ; Liou, Horng Huei ; Jeng, Jiann Shing ; Fu, Wen Mei. / Cytokine MIF Enhances Blood-Brain Barrier Permeability : Impact for Therapy in Ischemic Stroke. In: Scientific Reports. 2018 ; Vol. 8, No. 1.
@article{ba221ea5445f4801a38f9a6766f881e3,
title = "Cytokine MIF Enhances Blood-Brain Barrier Permeability: Impact for Therapy in Ischemic Stroke",
abstract = "Ischemic stroke is a devastating disease with limited therapeutic options. It is very urgent to find a new target for drug development. Here we found that the blood level of MIF in ischemic stroke patients is upregulated. To figure out the pathological role of MIF in ischemic stroke, both in vitro and in vivo studies were conducted. For in vitro studies, primary cortical neuron cultures and adult rat brain endothelial cells (ARBECs) were subjected to oxygen-glucose deprivation (OGD)/reoxygenation. Middle cerebral artery occlusion (MCAo) rodent models were used for in vivo studies. The results show that MIF exerts no direct neuronal toxicity in primary culture but disrupts tight junction in ARBECs. Furthermore, administration of MIF following MCAo shows the deleterious influence on stroke-induced injury by destroying the tight junction of blood-brain barrier and increasing the infarct size. In contrast, administration of MIF antagonist ISO-1 has the profound neuroprotective effect. Our results demonstrate that MIF might be a good drug target for the therapy of stroke.",
author = "Liu, {Yu Chuan} and Tsai, {Yung Hsu} and Tang, {Sung Chun} and Liou, {Houng Chi} and Kang, {Kai Hsiang} and Liou, {Horng Huei} and Jeng, {Jiann Shing} and Fu, {Wen Mei}",
year = "2018",
month = "12",
day = "1",
doi = "10.1038/s41598-017-16927-9",
language = "English",
volume = "8",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Cytokine MIF Enhances Blood-Brain Barrier Permeability

T2 - Impact for Therapy in Ischemic Stroke

AU - Liu, Yu Chuan

AU - Tsai, Yung Hsu

AU - Tang, Sung Chun

AU - Liou, Houng Chi

AU - Kang, Kai Hsiang

AU - Liou, Horng Huei

AU - Jeng, Jiann Shing

AU - Fu, Wen Mei

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Ischemic stroke is a devastating disease with limited therapeutic options. It is very urgent to find a new target for drug development. Here we found that the blood level of MIF in ischemic stroke patients is upregulated. To figure out the pathological role of MIF in ischemic stroke, both in vitro and in vivo studies were conducted. For in vitro studies, primary cortical neuron cultures and adult rat brain endothelial cells (ARBECs) were subjected to oxygen-glucose deprivation (OGD)/reoxygenation. Middle cerebral artery occlusion (MCAo) rodent models were used for in vivo studies. The results show that MIF exerts no direct neuronal toxicity in primary culture but disrupts tight junction in ARBECs. Furthermore, administration of MIF following MCAo shows the deleterious influence on stroke-induced injury by destroying the tight junction of blood-brain barrier and increasing the infarct size. In contrast, administration of MIF antagonist ISO-1 has the profound neuroprotective effect. Our results demonstrate that MIF might be a good drug target for the therapy of stroke.

AB - Ischemic stroke is a devastating disease with limited therapeutic options. It is very urgent to find a new target for drug development. Here we found that the blood level of MIF in ischemic stroke patients is upregulated. To figure out the pathological role of MIF in ischemic stroke, both in vitro and in vivo studies were conducted. For in vitro studies, primary cortical neuron cultures and adult rat brain endothelial cells (ARBECs) were subjected to oxygen-glucose deprivation (OGD)/reoxygenation. Middle cerebral artery occlusion (MCAo) rodent models were used for in vivo studies. The results show that MIF exerts no direct neuronal toxicity in primary culture but disrupts tight junction in ARBECs. Furthermore, administration of MIF following MCAo shows the deleterious influence on stroke-induced injury by destroying the tight junction of blood-brain barrier and increasing the infarct size. In contrast, administration of MIF antagonist ISO-1 has the profound neuroprotective effect. Our results demonstrate that MIF might be a good drug target for the therapy of stroke.

UR - http://www.scopus.com/inward/record.url?scp=85040798922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040798922&partnerID=8YFLogxK

U2 - 10.1038/s41598-017-16927-9

DO - 10.1038/s41598-017-16927-9

M3 - Article

AN - SCOPUS:85040798922

VL - 8

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 743

ER -